KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Common Equity (2018 - 2025)

Historic Common Equity for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $560.0 million.

  • Progyny's Common Equity rose 2877.33% to $560.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $560.0 million, marking a year-over-year increase of 2877.33%. This contributed to the annual value of $422.1 million for FY2024, which is 2373.69% down from last year.
  • Progyny's Common Equity amounted to $560.0 million in Q3 2025, which was up 2877.33% from $515.0 million recorded in Q2 2025.
  • In the past 5 years, Progyny's Common Equity ranged from a high of $571.6 million in Q1 2024 and a low of $184.6 million during Q1 2021
  • Over the past 5 years, Progyny's median Common Equity value was $424.4 million (recorded in 2023), while the average stood at $398.4 million.
  • In the last 5 years, Progyny's Common Equity skyrocketed by 7609.53% in 2021 and then crashed by 2373.69% in 2024.
  • Quarter analysis of 5 years shows Progyny's Common Equity stood at $251.8 million in 2021, then soared by 49.7% to $377.0 million in 2022, then skyrocketed by 46.81% to $553.4 million in 2023, then dropped by 23.74% to $422.1 million in 2024, then surged by 32.68% to $560.0 million in 2025.
  • Its Common Equity was $560.0 million in Q3 2025, compared to $515.0 million in Q2 2025 and $467.2 million in Q1 2025.